Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Adnot

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Investigation|August 1, 1994
Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic ratsC Kouyoumdjian, S Adnot, M Levame, et al.
Chest|February 1, 1993
Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency. Effects of indomethacinP Andrivet, J Cadranel, B Housset, et al.
Journal of Cardiovascular Pharmacology|September 1, 1993
Intracoronary linsidomine abolishes acetylcholine-induced vasoconstriction of epicardial coronary arteriesJ L Dubois-Rande, P Dupouy, H Geschwind, et al.
British Journal of Pharmacology|December 1, 1998
Effect of DMPPO, a phosphodiesterase type 5 inhibitor, on hypoxic pulmonary hypertension in ratsS Eddahibi, B Raffestin, A C Le Monnier de Gouville, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1997
Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injuryC Garat, C Jayr, S Eddahibi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in ratsS Eddahibi, S Adnot, E Frisdal, et al.
Chest|July 1, 1994
Intravenously administered atrial natriuretic factor in patients with COPD. Effects on ventilation-perfusion relationships and pulmonary hemodynamicsP Andrivet, P E Chabrier, C Defouilloy, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 1, 1988
Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxiaS Adnot, P E Chabrier, C Brun-Buisson, et al.
Biochemical and Biophysical Research Communications|September 30, 1982
Uncoupling by proteolysis of alpha-adrenergic receptor-mediated inhibition of adenylate cyclase in human plateletsN Ferry, S Adnot, A Borsodi, et al.
Archives of Pathology & Laboratory Medicine|July 1, 1994
Optimal handling of blood samples for routine measurement of lactate and pyruvateP Chariot, R Ratiney, M Ammi-Said, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Investigation|August 1, 1994
Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic ratsC Kouyoumdjian, S Adnot, M Levame, et al.
Chest|February 1, 1993
Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency. Effects of indomethacinP Andrivet, J Cadranel, B Housset, et al.
Journal of Cardiovascular Pharmacology|September 1, 1993
Intracoronary linsidomine abolishes acetylcholine-induced vasoconstriction of epicardial coronary arteriesJ L Dubois-Rande, P Dupouy, H Geschwind, et al.
British Journal of Pharmacology|December 1, 1998
Effect of DMPPO, a phosphodiesterase type 5 inhibitor, on hypoxic pulmonary hypertension in ratsS Eddahibi, B Raffestin, A C Le Monnier de Gouville, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1997
Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injuryC Garat, C Jayr, S Eddahibi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in ratsS Eddahibi, S Adnot, E Frisdal, et al.
Chest|July 1, 1994
Intravenously administered atrial natriuretic factor in patients with COPD. Effects on ventilation-perfusion relationships and pulmonary hemodynamicsP Andrivet, P E Chabrier, C Defouilloy, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 1, 1988
Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxiaS Adnot, P E Chabrier, C Brun-Buisson, et al.
Biochemical and Biophysical Research Communications|September 30, 1982
Uncoupling by proteolysis of alpha-adrenergic receptor-mediated inhibition of adenylate cyclase in human plateletsN Ferry, S Adnot, A Borsodi, et al.
Archives of Pathology & Laboratory Medicine|July 1, 1994
Optimal handling of blood samples for routine measurement of lactate and pyruvateP Chariot, R Ratiney, M Ammi-Said, et al.
Pageof 13